Title
Program
CEOT 2016 Program
Resolving the Organ Shortage: Practice, Policy and Politics
Thursday, February 25
2:30 pm |
Welcome |
2:45 - 4:45 pm |
Session 1: Optimizing the Use of Marginal Organs |
2:45 pm |
Administrative Strategies to Encourage Centers to use Marginal Organs |
3:15 pm |
Interventions in the Deceased Organ Donor to Improve Organ Quality |
3:45 pm |
The Organ Repair Center: Optimal Strategies to Repair Organs Ex Vivo |
4:15 pm | Best Practices at the Center Level to Safely Use Marginal Organs George Loss, MD, PhD, Ochsner Medical Center |
4:45 - 6:00 pm |
Reception and Posters |
6:00 - 7:30 pm |
Session 2: Keynotes |
6:00 pm |
Considerations Driving the Changes to Organ Allocation and Distribution |
6:30 pm |
A Congressional Perspective on Organ Transplantation & The Gift-of-Life |
7:00 pm |
Panel Discussion |
Friday, February 26
7:00 - 8:00 am |
Satellite Breakfast Symposium |
|
8:15 - 10:30 am |
Session 3: The New Era of Kidney Allocation Changes to Kidney Allocation: Gains and Losses KAS - Unintended Consequences and Future Changes Utilization of High KDPI Kidneys One year post KAS - A Tale of Two Transplant Centers Large program Discussion |
Increasing the Donor Heart Pool Introductory Remarks Means To Expand Heart Donation Mechanisms Of Immune Activation With Brain Death: Can This Be Modified? Brain Dead Donor Heart Management:Maintenance Of Hemodynamics With What Drugs? Data On Specific Inotropes/Pressors The Value Of Thyroid Hormone, Corticosteroids, Hypothermia And Other Means To Maintain/Improve Donor Heart Function Extended Criteria Donor Hearts: Defining Criteria And Outcomes Ex Vivo Heart Perfusion And DCD Heart Donation Panel Discussion
|
10:30 - 11:00 am |
Break |
|
11:00 - 12:30 pm |
Session 4: Removing Disincentives and Exploring Controversies of Incentives |
|
11:00 am |
World and Historical Perspectives |
|
11:30 am | Undue Incentives and Repugnant Transactions: One Economist's Perspective Alvin Roth, PhD, Stanford University |
|
12:00 pm |
Bioethical Perspectives on Incentivizing Organ Donation and the Impact of NOTA on Pilot Projects |
|
12:30 pm | What is an Incentive and a Critical Appraisal of Possible Pilot Trials of Incentives in Organ Donation? Robert S. Gaston, MD, University of Alabama at Birmingham Daniel R. Salomon, MD, Scripps Research Institute, and |
|
1:00 - 1:15 pm |
Break |
|
1:15 - 3:00 pm |
Session 5: Luncheon Workshop Discussing the Spectrum of Disincentives and Incentives: Afternoon Session with Audience Engagement: A structured discussion of the all issues related to disincentives and incentives with the aim of generating a position document Moderators: Robert S. Gaston, MD, University of Alabama at Birmingham and Daniel R. Salomon, MD, Scripps Research Institute |
|
3:15 - 7:00 pm |
Networking Activities Peak Your Interest on the Mountain |
Saturday, February 27
7:00 - 8:00 am |
Satellite Breakfast Symposium |
||||||
8:15 - 10:15 am |
Liver Allocation Benefits of Share 35 and Redistricting Concerns of Share 35 and Redistricting (Region 4 Data) Can MELD Be Improved? Implications of HCV Therapy and CKD Dual Organ Allocation Implications, Older NASH Patients, more CKD |
Donor Heart Selection Donor Heart Risk Factors Recipient Heart Risk Factors Intraoperative Risk Factors Associated with Heart Transplant Surgery and Mechanical Circulatory Support Patients - Special Considerations Immunologic Risk Factors: Approach to the Sensitized Patient Donor/Recipient Risk Scores: Review Of Published Approaches From Europe And the US Developing a Risk Score in Heart Transplantation Panel Discussion
|
|||||
10:15 - 10:45 am |
Break |
||||||
10:45 - 11:45 am |
Session 7: Update on Cardiac Transplantation Approach to Donor Heart Shortage Q&A Discussion Issues with the New Donor Heart Allocation Proposal Q&A Discussion |
||||||
11:45 - 2:00 pm |
Session 8: ESOT Luncheon Session Did the Last System Work? And Plans for the New Kidney Allocation in the UK Organ Allocation According to Eurotransplant Cardiothoracic Allocation in Europe Discussion - US Concepts vs EU Concepts |
||||||
2:00 - 2:15 pm |
Break - Move to parallel sessions |
||||||
2:15 - 4:15 pm
|
Session 9: Parallel Workshops |
||||||
Aligning Financial Incentives in New Systems of Allocation, Paired-Exchange, and Expanded Donation |
|||||||
Strategies to Expand the Liver Donor Pool Optimizing Living Donor Liver Transplant: Risks and Benefits Novel Strategies to Improve Function of Steatotic Donor Livers Increasing Use of DCD Livers: Are We Getting Better? |
|||||||
Long-term Risks to Living Kidney Donors Facilitator: John Gill, MD, MS, FAST, University of British Columbia Introduction John Gill, MD, MS, FAST, University of British Columbia Sentinel Events: Death and ESRD Dorry Segev, MD, PhD, FAST, Johns Hopkins University Non-sentinel Events: CKD, HTN, Diabetes, Depression Arthur Matas, MD, University of Minnesota Communication of Risk Dorry Segev and Arthur Matas |
|||||||
Getting the Message Across - Increased Infectious Risk Donors Improving Utilization of Organs from Increased Risk Donors: What We've Got Here is a Failure to Communicate Organ utilization / Risk Perception by Providers and Patients Risks of Other Donor-Derived Infections (nonHIV, nonHCV) |
|||||||
Discussion on the New UNOS Heart Allocation Proposal Overview of New Donor Heart Allocation Tiers Reassessing the Urgency of LVAD Patients Awaiting Transplantation Consider Options for Improved Zonal or Geographic Sharing Defining and Prioritizing Highly Sensitized Candidates Under-represented Populations Panel Discussion
|
|||||||
4:15 - 5:00 pm |
Break with refreshments (refreshments available throughout evening) |
||||||
5:00 PM - 6:20 PM | Session 10 (Choose one of two sessions) |
||||||
Where Are We Going With Kidney Paired Donation Moderators: Jesse Schold, PhD, MState, MEd, Cleveland Clinic and Richard Formica, MD, Yale University |
CASE STUDIES: REAL LIFE DONOR HEART OFFERS EXPERT PANEL |
||||||
5:00 PM | How Are We Measuring Sensitization? Anat Tambur, DMD, PhD, Northwestern University |
||||||
5:20 PM | Single Center Programs Work Best Adam Bingaman, MD, PhD, Texas Transplant Institute, San Antonio |
||||||
5:40 PM | A Nationally Run Private Program Works Best Stuart M. Flechner, MD, Cleveland Clinic |
||||||
6:00 PM | UNOS Should Oversee KPD Kenneth Andreoni, MD, University of Florida |
||||||
6:20 PM - 6:45 PM | Concluding Panel Discussion | ||||||
6:45 PM - 7:00 PM | Closing Remarks |